Tran Capital Management’s Elevance Health ELV Stock Holding History

Tran Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-36,817	Closed	-$14.3M	–	72
2025 Q2	$14.3M	Buy	+36,817	New	+$14.8M	1.69%	22
2020 Q1	–	Sell	-4,818	Closed	-$1.46M	–	68
2019 Q4	$1.46M	Sell	4,818 -67,031	-93%	-$18.4M	0.17%	48
2019 Q3	$17.3M	Sell	71,849 -2,459	-3%	-$674K	2.13%	22
2019 Q2	$21M	Sell	74,308 -24,476	-25%	-$6.69M	2.61%	19
2019 Q1	$28.3M	Sell	98,784 -18,679	-16%	-$5.4M	4.8%	8
2018 Q4	$30.8M	Sell	117,463 -39,873	-25%	-$11M	5.36%	6
2018 Q3	$43.1M	Sell	157,336 -7,163	-4%	-$1.86M	5.34%	7
2018 Q2	$39.2M	Sell	164,499 -5,820	-3%	-$1.35M	5.25%	7
2018 Q1	$37.4M	Sell	170,319 -4,194	-2%	-$985K	4.86%	7
2017 Q4	$39.3M	Sell	174,513 -21,432	-11%	-$4.56M	3.73%	8
2017 Q3	$37.2M	Sell	195,945 -4,658	-2%	-$887K	3.34%	11
2017 Q2	$37.7M	Buy	+200,603	New	+$36M	3.4%	12

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Tran Capital Management's ELV Position: Q3 2025 in Review

Tran Capital Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 36,817 shares — an estimated $14.3M sold.

Tran Capital Management first reported a position in ELV in Q2 2017 and held it in 12 quarters. The position peaked at $43.1M in Q3 2018. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

Tran Capital Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
Tran Capital Management sold 36,817 Elevance Health shares in Q3 2025, an estimated $14.3M.
Tran Capital Management first reported a position in Elevance Health in Q2 2017 and held it in 12 quarters.
Tran Capital Management's Elevance Health position peaked at $43.1M in Q3 2018.
1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Tran Capital Management's 13F filing for Q3 2025, filed 23 Oct 2025.